Trabeculopuncture as Predictive Test for the Success of Ab Interno Trabeculectomy
Launched by WUERZBURG UNIVERSITY HOSPITAL · Jul 23, 2024
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a procedure called trabeculopuncture to see if it can help predict how successful another procedure, called ab interno trabeculectomy, will be in treating certain types of glaucoma, specifically open-angle glaucoma and pseudoexfoliation glaucoma. Trabeculopuncture is a test that checks how well fluid drains from the eye, which is important for managing eye pressure.
To participate in this trial, individuals must be at least 18 years old and have a type of glaucoma that isn’t well controlled with medication. They should also have signs of worsening eye health, like thinning of a specific part of the eye’s nerve layer or worsening vision. Participants can expect to undergo the trabeculopuncture test, which will help determine if they are good candidates for the trabeculectomy procedure. It's important to note that individuals with certain types of glaucoma, previous eye surgeries, or specific health conditions affecting eye pressure won't be eligible for this trial. This study is currently recruiting participants, so if you fit the criteria, there may be an opportunity to contribute to valuable research in glaucoma treatment.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • individuals ≥ 18 years of age
- • clinical diagnosis of: primary open angle glaucoma, pigmentary glaucoma, or pseudoexfoliation glaucoma
- • uncontrolled intraocular pressure (IOP) with maximally tolerated medical therapy
- • progressive thinning of retinal nerve fiber layer assessed by Spectral domain optical coherence tomography (p \< 0.05)
- • progression of visual field defects
- • visually significant cataract and indication to reduce IOP or glaucoma medication burden
- Exclusion Criteria:
- • clinical diagnosis of neovascular glaucoma, angle-closure glaucoma, uveitic glaucoma, neovascular glaucoma
- • prior glaucoma surgery
- • preexisting conditions affecting the episcleral venous pressure including Grave's ophthalmopathy, Sturge-Weber syndrome, Arteriovenous fistulas (carotid-cavernous fistula)
About Wuerzburg University Hospital
Würzburg University Hospital, a leading academic medical center in Germany, is dedicated to advancing healthcare through innovative research and clinical trials. As a prominent institution within the University of Würzburg, it combines cutting-edge scientific inquiry with comprehensive patient care. The hospital is committed to improving medical outcomes by fostering collaboration among multidisciplinary teams and leveraging state-of-the-art facilities. With a focus on translating research findings into practical applications, Würzburg University Hospital plays a pivotal role in driving medical advancements and enhancing patient quality of life.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Würzburg, Bavaria, Germany
Patients applied
Trial Officials
Daniel Kampik, MD, PhD
Principal Investigator
Department of Ophthalmology University Hospital Würzburg
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported